Literature DB >> 20872342

Bortezomib-associated late hepatitis B reactivation in a case of multiple myeloma.

Selvihan Beysel, Zeynep Arzu Yeğın, Münci Yağci.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20872342     DOI： 10.4318/tjg.2010.0087

Source DB:  PubMed          Journal:  Turk J Gastroenterol        ISSN： 1300-4948            Impact factor:   1.852


× No keyword cloud information.
  8 in total

Review 1.  Hepatitis B Reactivation Associated With Immune Suppressive and Biological Modifier Therapies: Current Concepts, Management Strategies, and Future Directions.

Authors:  Rohit Loomba; T Jake Liang
Journal:  Gastroenterology       Date:  2017-02-20       Impact factor: 22.682

2.  Infectious complications in multiple myeloma receiving autologous stem cell transplantation in the past 10 years.

Authors:  Hyunkyung Park; Jeonghwan Youk; Hak Ro Kim; Youngil Koh; Ji Hyun Kwon; Sung-Soo Yoon; Seonyang Park; Pyoeng Gyun Choe; Nam Joong Kim; Myoung-Don Oh; Wan Beom Park; Inho Kim
Journal:  Int J Hematol       Date:  2017-08-20       Impact factor: 2.490

Review 3.  Hepatitis B Virus Reactivation: Risk Factors and Current Management Strategies.

Authors:  Danielle J Smalls; Reagan E Kiger; LeAnn B Norris; Charles L Bennett; Bryan L Love
Journal:  Pharmacotherapy       Date:  2019-11-03       Impact factor: 4.705

4.  Hepatitis B Reactivation Rate and Fate Among Multiple Myeloma Patients Receiving Regimens Containing Lenalidomide and/or Bortezomib

Authors:  Pınar Ataca Atilla; Merih Yalçıner; Erden Atilla; Ramazan İdilman; Meral Beksaç
Journal:  Turk J Haematol       Date:  2019-08-01       Impact factor: 1.831

5.  Bortezomib induced hepatitis B reactivation.

Authors:  Salwa Hussain; Ruby Jhaj; Samira Ahsan; Muhammad Ahsan; Robert E Bloom; Syed-Mohammed R Jafri
Journal:  Case Rep Med       Date:  2014-05-04

Review 6.  Immunosuppression in Patients with Chronic Hepatitis B.

Authors:  Anil Seetharam; Robert Perrillo; Robert Gish
Journal:  Curr Hepatol Rep       Date:  2014-06-21

7.  Efficacy and Safety of Bortezomib in Multiple Myeloma Patients with Hepatitis B: A Multicenter Retrospective Study.

Authors:  Jin Lu; Wen-Ming Chen; Chuan-Ying Geng; Brian Gm Durie; Xiao-Jun Huang
Journal:  Chin Med J (Engl)       Date:  2016-02-05       Impact factor: 2.628

8.  Clearance of HBsAg in a patient with familial multiple myeloma after a bortezomib-based regimen combined with anti-HBV drug: A case report.

Authors:  Xuzhao Zhang; Yun Liang; Xian Li; Weiqin Wang; Jiefeng Tong; Yang Xu
Journal:  Medicine (Baltimore)       Date:  2020-10-02       Impact factor: 1.817
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.